Last checked at 8 Apr 2015 07:00
Avacta Group plc
("Avacta" or "the Group")
Notice of Results
Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare will be reporting its interim results for the six months ended 31 January 2015 on Tuesday 28 April 2015.
Alastair Smith, CEO and Tim Sykes, FD will be hosting a briefing for analysts on Tuesday 28 April 2015 at 9.30am at the London Capital Club, 15 Abchurch Lane, London, EC4N 7BW.
For more information or to register to attend the briefing contact Walbrook PR (contact details below).
Enquiries:
Avacta Group plc Alastair Smith, Chief Executive Officer Tim Sykes, Chief Financial Officer | Tel: +44 (0) 844 414 0452 www.avacta.com |
Numis Securities Limited Michael Meade / Freddie Barnfield - Nominated Adviser James Black - Corporate Broking | Tel: +44 (0) 207 260 1000 www.numiscorp.com |
Media Enquiries Walbrook PR Ltd Mike Wort / Anna Dunphy | Tel: +44 (0) 207 933 8780 avacta@walbrookpr.com |
About Avacta Group plc - www.avacta.com Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through three divisions:
| |||||||